EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Evaluating risk factors in recurrent pregnancy loss: A prospective cohort study and its impact on live birth outcomes

Josefine Reinhardt Nielsen, Astrid Marie Kolte, Sofie Bliddal, Henrik Løvendahl Jørgensen, Morten Guldborg Johnsen, Maria Christine Krog, David Westergaard, Henriette Svarre Nielsen

Journal of Reproductive Immunology · 2024

DOI: 10.1016/j.jri.2024.104297 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Reproductive Immunology, 2024. Verfasst von Josefine Reinhardt Nielsen und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Recurrent Pregnancy Loss Unit, The Capital Region, Copenhagen University Hospitals, Hvidovre Hospital, DK-2650, Rigshospitalet, Copenhagen DK-210…. Hauptthemen laut MEDLINE: Abortion, Habitual, Live Birth. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk AS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent pregnancy loss (RPL) affects 1-2 % of all couples trying to conceive and is a challenging heterogeneous condition. This study aimed to evaluate the prevalence and impact of various risk factors in patients suffering from RPL. We performed a prospective cohort study including patients at the tertiary RPL Unit in the Capital Region of Denmark between 1st January 2000 and 1st January 2023. The main outcome of the study was the first pregnancy after referral and whether the pregnancy was ongoing at least to the 22nd gestational week. A total of 2555 patients were included in the study, out of whom 1892 patients achieved a pregnancy after referral to the RPL Unit. This resulted in 1103 live births (58.3 %) and 718 pregnancy losses (37.9 %). Maternal age, BMI, smoking status and the number of prior pregnancy losses were negatively correlated with the likelihood of achieving pregnancy. Furthermore, maternal age, prior pregnancy losses, antiphospholipid syndrome (APS) and uterine malformations were associated with reduced birth rates. Patients with secondary RPL had a higher birth rate compared to those with primary RPL, and patients with APS treated with low-molecular-weight heparin (LMWH) demonstrated a significantly increased birth rate compared to untreated APS patients. These findings suggest that certain risk factors significantly impact the likelihood of achieving pregnancy and live birth following RPL, which can be used in patient guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, HabitualLive BirthHumansFemalePregnancyAdultProspective StudiesRisk FactorsAntiphospholipid SyndromeMaternal AgeDenmarkPregnancy OutcomeHeparin, Low-Molecular-WeightBirth RateCohort Studies

Stichwörter der Autor:innen

Cohort studyLive birthPregnancyRecurrent pregnancy lossRisk factors

Substanzen

Heparin, Low-Molecular-Weight

Autor:innen und Institutionen

  • The Recurrent Pregnancy Loss Unit, The Capital Region, Copenhagen University Hospitals, Hvidovre Hospital, DK-2650, Rigshospitalet, Copenhagen DK-2100, Denmark. Electronic address: josefine.reinhardt.nielsen@regionh.dk.
  • The Recurrent Pregnancy Loss Unit, The Capital Region, Copenhagen University Hospitals, Hvidovre Hospital, DK-2650, Rigshospitalet, Copenhagen DK-2100, Denmark; Institute of Clinical Medicine, Faculty of Health and Medi…
  • Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark; Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen…
  • Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark; Department of Clinical Biochemistry, Copenhagen University Hospital Hvidovre, Hvidovre, Denm…
  • The Recurrent Pregnancy Loss Unit, The Capital Region, Copenhagen University Hospitals, Hvidovre Hospital, DK-2650, Rigshospitalet, Copenhagen DK-2100, Denmark.
  • The Recurrent Pregnancy Loss Unit, The Capital Region, Copenhagen University Hospitals, Hvidovre Hospital, DK-2650, Rigshospitalet, Copenhagen DK-2100, Denmark; Department of Obstetrics and Gynaecology, Copenhagen Unive…

Förderung

  • Novo Nordisk AS

Zitieren

APA

Nielsen, J. R., Kolte, A. M., Bliddal, S., Jørgensen, H. L., Johnsen, M. G., Krog, M. C., Westergaard, D., & Nielsen, H. S. (2024). Evaluating risk factors in recurrent pregnancy loss: A prospective cohort study and its impact on live birth outcomes. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2024.104297

Vancouver

Nielsen JR, Kolte AM, Bliddal S, Jørgensen HL, Johnsen MG, Krog MC, et al. Evaluating risk factors in recurrent pregnancy loss: A prospective cohort study and its impact on live birth outcomes. Journal of Reproductive Immunology. 2024. doi:10.1016/j.jri.2024.104297

BibTeX
@article{Nielsen2024,
  author = {Nielsen, Josefine Reinhardt and Kolte, Astrid Marie and Bliddal, Sofie and Jørgensen, Henrik Løvendahl and Johnsen, Morten Guldborg and Krog, Maria Christine and Westergaard, David and Nielsen, Henriette Svarre},
  title = {Evaluating risk factors in recurrent pregnancy loss: A prospective cohort study and its impact on live birth outcomes},
  journal = {Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1016/j.jri.2024.104297}
}
Kostenlos starten →